UHPLC/Q-TOFMS-based plasma metabolomics of polycystic ovary syndrome patients with and without insulin resistance.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Pharmaceutical and Biomedical Analysis

• Publication date

  2016-03-20

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jpba.2016.01.025PMID 26808063
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Follicular metabolic changes and effects on oocyte quality in polycystic ovary syndrome patients

  2017cited by this paper
• Lipidomics reveals altered biosynthetic pathways of glycerophospholipids and cell signaling as biomarkers of the polycystic ovary syndrome

  2017cited by this paper
• Concurrent profiling of polar metabolites and lipids in human plasma using HILIC-FTMS

  2016cited by this paper
• Serum metabolomics study of polycystic ovary syndrome based on UPLC-QTOF-MS coupled with a pattern recognition approach

  2015cited by this paper
• UPLC-HRMS based metabolomics reveals the sphingolipids with long fatty chains and olefinic bonds up-regulated in metabolic pathway for hypoxia preconditioning.

  2015cited by this paper
• Metabolomic investigation of human diseases biomarkers by CE and LC coupled to MS

  2014cited by this paper
• Characterizing plasma phospholipid fatty acid profiles of polycystic ovary syndrome patients with and without insulin resistance using GC-MS and chemometrics approach.

  2014cited by this paper
• Polycystic ovary syndrome – Phenotypes and diagnosis

  2014cited by this paper
• Serum metabolomics study of polycystic ovary syndrome based on liquid chromatography-mass spectrometry.

  2014cited by this paper
• The role of phosphatidylcholine and choline metabolites to cell proliferation and survival

  2013cited by this paper
• Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

  2012cited by this paper
• Inflammation in Polycystic Ovary Syndrome: underpinning of insulin resistance and ovarian dysfunction.

  2012cited by this paper
• Metabonomics reveals plasma metabolic changes and inflammatory marker in polycystic ovary syndrome patients.

  2012cited by this paper
• Metabolomic biomarkers in women with polycystic ovary syndrome: a pilot study.

  2012cited by this paper
• Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis

  2012cited by this paper
• Plasma Lysophosphatidylcholine Levels Are Reduced in Obesity and Type 2 Diabetes

  2012cited by this paper
• Metabolic heterogeneity in polycystic ovary syndrome is determined by obesity: plasma metabolomic approach using GC-MS.

  2012cited by this paper
• Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry

  2011cited by this paper
• Differences between Human Plasma and Serum Metabolite Profiles

  2011cited by this paper
• Differences in metabolite profile between blood plasma and serum.

  2010cited by this paper
• Lysophosphatidylcholine Activates Adipocyte Glucose Uptake and Lowers Blood Glucose Levels in Murine Models of Diabetes*

  2009cited by this paper
• Heirarchical clustering and beyond in PCOS endometrium: brave new world.

  2009cited by this paper
• Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation.

  2008cited by this paper
• A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system.

  2008cited by this paper
• The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.

  2008cited by this paper
• Metabolomics: a global biochemical approach to drug response and disease.

  2008cited by this paper
• Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies.

  2008cited by this paper
• Role of lysophosphatidylcholine (LPC) in atherosclerosis.

  2007cited by this paper
• Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts

  2007cited by this paper
• Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline.

  2006cited by this paper
• Metabolomics: The greatest omics of them all?

  2006cited by this paper
• Diagnostic criteria for polycystic ovary syndrome: a reappraisal.

  2005cited by this paper
• Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.

  2004cited by this paper
• Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

  2004cited by this paper
• A prospective randomized study comparing pregnancy rates and implantation rates when embryos are selected based on a graduated embryo score (GES) vs. a single day 3 (D.3) score

  2004cited by this paper
• Formal consensus: the development of a national clinical guideline

  2001cited by this paper
• The development of the polycystic ovary syndrome: family history as a risk factor.

  1998cited by this paper
• Polycystic ovary syndrome.

  1995cited by this paper
• Evidence for Distinctive and Intrinsic Defects in Insulin Action in Polycystic Ovary Syndrome

  1992cited by this paper
• Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man

  1985cited by this paper
• Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease.

  1980cited by this paper
• Bioinformatics Applications Note Systems Biology Metpa: a Web-based Metabolomics Tool for Pathway Analysis and Visualization

  year unknowncited by this paper

• Metabolite and gut microbiota co-biomarkers in Danggui Shaoyao San: insights into a shared therapeutic approach

  2026cites this paper
• The Potential of Volatilomics as Female Fertilization Biomarkers in Assisted Reproductive Techniques.

  2026cites this paper
• Lipidomics Reveals Common Mechanisms in Polycystic Ovarian Syndrome, Recurrent Spontaneous Abortion, and Infertility: A Genetic-Based Analysis

  2025cites this paper
• Mass spectrometry-based untargeted metabolomics study of polycystic ovary syndrome

  2025cites this paper
• Integrated Metabolomics Using Data‐Dependent Acquisition and Data‐Independent Acquisition and Network Pharmacology to Reveal the Mechanisms of Usnic Acid in Treating Non–Small Cell Lung Cancer

  2025cites this paper
• Biomarkers identification in follicular fluid in relation to live birth in in vitro fertilization of women with polycystic ovary syndrome in different subtypes by using UPLC-MS method.

  2024cites this paper
• Insight into metabolic dysregulation of polycystic ovary syndrome utilizing metabolomic signatures: a narrative review

  2024cites this paper
• Integrating Metabolomics and Network Pharmacology to Explore the Mechanism of Tongmai Yangxin Pills in Ameliorating Doxorubicin-Induced Cardiotoxicity

  2023cites this paper
• Blood Volatile Organic Compounds as potential biomarkers for poly cystic ovarian syndrome (PCOS): An animal study in the PCOS rat model.

  2022cites this paper
• Follicular Fluid: A Powerful Tool for the Understanding and Diagnosis of Polycystic Ovary Syndrome

  2022cites this paper
• Seaweed metabolomics: A review on its nutrients, bioactive compounds and changes in climate change.

  2022cites this paper
• Effects of L-carnitine supplementation for women with polycystic ovary syndrome: a systematic review and meta-analysis

  2022cites this paper
• Untargeted metabolomic approach to study the serum metabolites in women with polycystic ovary syndrome

  2021cites this paper
• Metabolomic Biomarkers in Polycystic Ovary Syndrome: A Review of the Evidence

  2021cites this paper
• Untargeted metabolomic approach to study the serum metabolites in women with polycystic ovary syndrome

  2021cites this paper
• Zearalenone-induced aberration in the composition of the gut microbiome and function impacts the ovary reserve.

  2020cites this paper
• Metabolomic Biomarkers in Gynecology: a Treasure Path or a False Path?

  2020cites this paper
• Characterization of the cold and hot natures of raw and processed Rehmanniae Radix by integrated metabolomics and network pharmacology.

  2020cites this paper
• Using Fourier Transform Infrared (FTIR) Spectroscopy Coupled with Multivariate Analysis to Diagnose Polycystic Ovary Syndrome (PCOS)

  2020cites this paper
• Untargeted metabolomics analysis of serum and follicular fluid samples from women with polycystic ovary syndrome.

  2020cites this paper
• Untargeted metabolomics changes on Gammarus pulex induced by propranolol, triclosan, and nimesulide pharmaceutical drugs.

  2020cites this paper
• Characterization of serum metabolites as biomarkers of carbon black nanoparticles-induced subchronic toxicity in rats by hybrid triple quadrupole time-of-flight mass spectrometry with non-targeted metabolomics strategy.

  2019cites this paper
• Changes in whole metabolites after exenatide treatment in overweight/obese polycystic ovary syndrome patients

  2019cites this paper
• Follicular dynamics of glycerophospholipid and sphingolipid metabolisms in polycystic ovary syndrome patients.

  2019cites this paper
• Current Progress of Lipid Analysis in Metabolic Diseases by Mass Spectrometry Methods.

  2019cites this paper
• Cell metabolomics to study the cytotoxicity of carbon black nanoparticles on A549 cells using UHPLC-Q/TOF-MS and multivariate data analysis.

  2019cites this paper
• Novel circular RNA expression in the cumulus cells of patients with polycystic ovary syndrome

  2019cites this paper
• Alterations of Sphingolipid Metabolism in Different Types of Polycystic Ovary Syndrome

  2019cites this paper
• Identification of the metabolic fingerprints in women with polycystic ovary syndrome using the multiplatform metabolomics technique.

  2019cites this paper
• On the Concepts and History of Glioblastoma Multiforme - Morphology, Genetics and Epigenetics

  2018cites this paper
• Concentrations plasmatiques d'acides amines et d'acylcarnitines en relation avec le statut ponderal chez les adolescents de la Polynésie Française

  2018cites this paper
• UPLC/Q-TOF-MS based plasma metabolomics and clinical characteristics of polycystic ovarian syndrome

  2018cites this paper
• Metabolomic changes induced by nicotine in adult zebrafish skeletal muscle.

  2018cites this paper
• UPLC/Q-TOF-MS-based metabolomics study of the anti-osteoporosis effects of Achyranthes bidentata polysaccharides in ovariectomized rats.

  2018cites this paper
• Lipidomics reveals altered biosynthetic pathways of glycerophospholipids and cell signaling as biomarkers of the polycystic ovary syndrome

  2017cites this paper
• Follicular metabolic changes and effects on oocyte quality in polycystic ovary syndrome patients

  2017cites this paper
• Concurrent profiling of polar metabolites and lipids in human plasma using HILIC-FTMS

  2016cites this paper